Chugai Pharmaceutical Co., Ltd. - Company Profile and SWOT Analysis
Summary
Chugai Pharmaceutical Co., Ltd. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Chugai Pharmaceutical Co., Ltd. (Chugai or 'the company') is involved in bio-pharmaceutical research and development. The company offers medical products and services for human health. Chugai produces antibody drugs that focus on oncology, hematology, immunology, neuroscience, infectious diseases, and joint diseases. The company's product portfolio includes Actemra (tocilizumab), Alfarol, Avastin (bevacizumab), Bonviva (ibandronate), CellCept (mycophenolate mofetil), Tamiflu (oseltamivir phosphate), Edirol (eldecalcitol), Kadcyla (trastuzumab emtansine), Kytril, and Mircera (epoetin beta pegol). Chugai operates and markets its products in North America, Europe and Asia. The company is headquartered in Tokyo, Japan.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook